BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26722059)

  • 21. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements.
    Ocal N; Yildiz B; Karadurmus N; Dogan D; Ozaydin S; Ocal R; Ozturk M; Arpaci F; Bilgic H
    Onco Targets Ther; 2016; 9():7445-7450. PubMed ID: 28003760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].
    Baume D; Pico JL; Droz JP; Ostronoff M; Azab M; Gilles E; Ghosn M; Salloum E; Gouyette A; Beaujean F
    Bull Cancer; 1990; 77(2):169-80. PubMed ID: 2156588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors and results of treating 42 patients with nln-seminomatous germ cell tumor of the testis].
    Czownicki Z; Rogozińska J; Choina B
    Pol Tyg Lek; 1996 Feb; 51(6-9):82-5. PubMed ID: 8756738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
    De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
    Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of chemotherapy for advanced testicular and extragonadal germ cell tumors: a single-center 27-year experience.
    Tanaka T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T
    Jpn J Clin Oncol; 2010 Jan; 40(1):73-8. PubMed ID: 19773268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary mediastinal germ cell tumors].
    Yoshitake T
    Kyobu Geka; 1990 Jul; 43(7):582-92. PubMed ID: 2168496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
    Faure-Conter C; Orbach D; Cropet C; Baranzelli MC; Martelli H; Thebaud E; Vérité C; Rome A; Fasola S; Corradini N; Rocourt N; Frappaz D; Kalfa N; Patte C
    Pediatr Blood Cancer; 2014 Feb; 61(2):253-9. PubMed ID: 23940114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
    Suleiman Y; Siddiqui BK; Brames MJ; Abonour R; Einhorn LH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):161-3. PubMed ID: 22892555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
    Vaena DA; Abonour R; Einhorn LH
    J Clin Oncol; 2003 Nov; 21(22):4100-4. PubMed ID: 14615439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose chemotherapy and stem cell rescue for metastatic germ cell tumours: long-term results from a single institution.
    Kruse V; Noens L; Lumen N; Hoebeke P; Van Belle S; Rottey S
    Acta Clin Belg; 2011; 66(4):254-9. PubMed ID: 21938979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
    Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
    J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
    Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
    Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study on poor-risk patients with non-seminomatous germ cell tumor].
    Okamura K; Takashi M; Hibi H; Tsuji Y; Shimoji T; Ohshima S; Takagi Y; Suzuki Y; Mizutani K; Ono Y; Kato T; Kobayashi M
    Hinyokika Kiyo; 1998 Apr; 44(4):265-72. PubMed ID: 9617623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.